八旬患者主动脉瓣置换术后生存、功能生存与再入院预测因素
该回顾性队列研究分析了1995至2014年加拿大曼尼托巴省378例≥80岁接受主动脉瓣置换术(SAVR)的患者,其中55%同期行冠脉搭桥。结果显示八旬患者院内死亡率8.5%,1年和5年功能生存率分别为82.4%和56.5%,免于再入院率分别为61.5%和28.4%。术前房颤、外周血管病、女性、术后急性肾损伤和输血与不良结局相关。
要点
- 八旬患者SAVR术后1年功能生存率82.4%,5年56.5%。
- 术后1年免于再入院率61.5%,5年降至28.4%。
- 术前房颤、外周血管病、女性、术后急性肾损伤和输血提示不良结局。
核心结论
- 在符合条件的八旬患者中,SAVR的1年和5年功能生存率及再入院率可接受,但围术期死亡和并发症显著。
研究设计与样本
- 回顾性队列研究,纳入1995至2014年曼尼托巴省≥80岁接受SAVR(伴或不伴冠脉搭桥)的患者378例,其中55%(n=208)同期行冠脉搭桥。
主要发现
- 八旬患者院内死亡率为8.5%(P <.001),中位ICU停留47.2小时(P <.001),中位住院13天(P <.001)。
- 中位随访5.2年,1年功能生存率82.4%,5年56.5%;1年免于再入院率61.5%,5年28.4%。
- 生存率在1年(83.8%)和5年(60.8%)接近年龄和性别匹配的预期寿命。
- 术前房颤、外周血管病、女性、术后急性肾损伤和输血与不良结局相关。
临床怎么用
- 对于八旬主动脉瓣狭窄患者,SAVR可作为可选方案,但需充分评估围术期风险并告知功能生存和再入院可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze outcomes and predictors of functional survival (personal care home admission and mortality) and hospital readmission in patients aged ≥80 years who underwent surgical aortic valve replacement (SAVR) in a Manitoba hospital. METHODS: This was a retrospective cohort study of patients aged ≥80 years who underwent SAVR with or without coronary artery bypass grafting in Manitoba between 1995 and 2014. Data from the Manitoba Adult Cardiac Surgery database and the Manitoba Centre for Health Policy were used. Kaplan-Meier estimates of outcomes and Cox multivariate regression analysis of risk factors were performed. Survival was compared with that of age- and sex-matched life expectancy. RESULTS: A total of 1872 patients were aged ≥50 years and 378 were aged ≥80 years, 55% of whom (n = 208) underwent concurrent coronary artery bypass grafting. Compared with younger patients, octogenarians had higher in-hospital mortality (8.5%; P <.001), longer median intensive care unit stay (47.2 hours; P <.001), and longer median in-hospital stay (13 days; P <.001). The median follow-up was 5.2 years. Functional survival was 82.4% at 1 year and 56.5% at 5 years, and freedom from hospital readmission was 61.5% at 1 year and 28.4% at 5 years. Survival approximated the age- and sex-matched life expectancy at 1 year (83.8%) and 5 years (60.8%). Preoperative atrial fibrillation, peripheral vascular disease, female sex, postoperative acute kidney injury, and blood transfusion were associated with adverse outcomes. CONCLUSIONS: In eligible octogenarians, SAVR has acceptable 1- and 5-year functional survival and hospital readmission rates, but significant perioperative mortality and morbidity.
引用
- Kuo K, Shah P, Hiebert B, et al. Predictors of survival, functional survival, and hospital readmission in octogenarians after surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2017. PMID: 28673707. doi:10.1016/j.jtcvs.2017.05.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。